Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good day, and welcome to The Hanover Insurance Group’s Fourth ...

Lonza Group AG plans to focus on CDMO segment, despite revenue decrease. Click here to read more on the analysis of LZAGY stock.

The shares have sprung back to life thanks to China’s new stimulus programs—and Alibaba’s AI ventures. They stand to gain as much as 48%.